Seattle Startup Singletto Gains FDA Approval for Virus-Killing Oxafence Surgical Masks

Seattle startup Singletto received FDA approval for its Oxafence technology, a methylene blue-treated surgical mask that kills 99.9% of certain viruses within five minutes. The masks are already in use in New Zealand and represent a significant advancement over traditional masks by actively inactivating pathogens.

TThomas Lendvay JJohn Bjornson TTend SSingletto